Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 5/2021

06.07.2020 | Otology

Grading system and surgical approaches for endolymphatic sac tumors

verfasst von: Feitian Li, Yibo Zhang, Wei Li, Qianru Wu, Dedi Kong, Xunbei Shi, Chunfu Dai

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Endolymphatic sac tumors (ELSTs) are rare, low-grade adenocarcinomas arising from the endolymphatic sac. This study aims to present a novel grading system for ELSTs to determine the optimal management strategy.

Methods

We performed a retrospective analysis of 16 patients with 17 ELSTs. The tumor location and involved adjacent neurovascular structures on CT and MRI were selected to establish the grading system.

Results

Based on the novel grading system, grade III a tumors were most common (7/17), followed by grade I (4/17), grade II (3/17), and grade III b (3/17) tumors. Eight advanced ELSTs (grade III a and III b) received an infra-temporal fossa approach, while the other 6 early stage ELSTs (grade I and II) underwent either a retrolabyrinthine approach with posterior petrosectomy or a translabyrinthine approach combined with subtotal temporal bone resection. Hearing preservation was achieved in 2 grade I patients. Postoperative facial nerve function was HB II in 1 grade III a patient who underwent anterior facial nerve transposition and was HB III in 4 advanced patients who received facial nerve grafts with the great auricular nerve or facial-hypoglossal nerve anastomosis. The mean follow-up time was 35.1 months. Two grade III patients and 1 grade II patient had tumor recurrence during follow-up, among whom 1 grade III b patient had two cases of recurrence.

Conclusion

A correct initial diagnosis was established in all patients after meticulous imaging studies. Surgical resection is still the first choice to manage patients with ELSTs. The novel grading system enables surgeons to select tailored surgical approaches. Long-term follow-up is necessary following surgical intervention.
Literatur
1.
Zurück zum Zitat Megerian CA, McKenna MJ, Nuss RC et al (1995) Endolymphatic sac tumors: histopathologic confirmation, clinical characterization, and implication in von Hippel-Lindau disease. Laryngoscope 105:801–808CrossRef Megerian CA, McKenna MJ, Nuss RC et al (1995) Endolymphatic sac tumors: histopathologic confirmation, clinical characterization, and implication in von Hippel-Lindau disease. Laryngoscope 105:801–808CrossRef
2.
Zurück zum Zitat Megerian CA, Semaan MT (2007) Evaluation and management of endolymphatic sac and duct tumors. Otolaryngol Clin N Am 40:463–478CrossRef Megerian CA, Semaan MT (2007) Evaluation and management of endolymphatic sac and duct tumors. Otolaryngol Clin N Am 40:463–478CrossRef
3.
Zurück zum Zitat Heffner DK (1989) Low-grade adenocarcinoma of probable endolymphatic sac origin A clinicopathologic study of 20 cases. Cancer 64:2292–2302CrossRef Heffner DK (1989) Low-grade adenocarcinoma of probable endolymphatic sac origin A clinicopathologic study of 20 cases. Cancer 64:2292–2302CrossRef
4.
Zurück zum Zitat Lonser RR, Kim HJ, Butman JA, Vortmeyer AO, Choo DI, Oldfield EH (2004) Tumors of the endolymphatic sac in von Hippel-Lindau disease. N Engl J Med 350:2481–2486CrossRef Lonser RR, Kim HJ, Butman JA, Vortmeyer AO, Choo DI, Oldfield EH (2004) Tumors of the endolymphatic sac in von Hippel-Lindau disease. N Engl J Med 350:2481–2486CrossRef
5.
Zurück zum Zitat Kirsh ER, Kozin ED, Knoll RM et al (2018) Sequential imaging in patient with suspected Meniere's disease identifies endolymphatic sac tumor. Otol Neurotol 39:e856–e859CrossRef Kirsh ER, Kozin ED, Knoll RM et al (2018) Sequential imaging in patient with suspected Meniere's disease identifies endolymphatic sac tumor. Otol Neurotol 39:e856–e859CrossRef
6.
Zurück zum Zitat Patel NP, Wiggins RH 3rd, Shelton C (2006) The radiologic diagnosis of endolymphatic sac tumors. Laryngoscope 116(1):40–46CrossRef Patel NP, Wiggins RH 3rd, Shelton C (2006) The radiologic diagnosis of endolymphatic sac tumors. Laryngoscope 116(1):40–46CrossRef
7.
Zurück zum Zitat Butman JA, Nduom E, Kim HJ, Lonser RR (2013) Imaging detection of endolymphatic sac tumor-associated hydrops. J Neurosurg 119:406–411CrossRef Butman JA, Nduom E, Kim HJ, Lonser RR (2013) Imaging detection of endolymphatic sac tumor-associated hydrops. J Neurosurg 119:406–411CrossRef
8.
Zurück zum Zitat Kitahara T, Maekawa C, Kizawa K, Kamakura T, Horii A, Inohara H (2011) Endolymphatic sac tumor with overexpression of V2 receptor mRNA and inner ear hydrops. Acta Otolaryngol 131:951–957CrossRef Kitahara T, Maekawa C, Kizawa K, Kamakura T, Horii A, Inohara H (2011) Endolymphatic sac tumor with overexpression of V2 receptor mRNA and inner ear hydrops. Acta Otolaryngol 131:951–957CrossRef
9.
Zurück zum Zitat Bambakidis NC, Megerian CA, Ratcheson RA (2004) Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status. Otol Neurotol 25(5):773–781CrossRef Bambakidis NC, Megerian CA, Ratcheson RA (2004) Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status. Otol Neurotol 25(5):773–781CrossRef
10.
Zurück zum Zitat Devaney KO, Ferlito A, Rinaldo A (2003) Endolymphatic sac tumor (low-grade papillary adenocarcinoma) of the temporal bone. Acta Otolaryngol 123:1022–1026CrossRef Devaney KO, Ferlito A, Rinaldo A (2003) Endolymphatic sac tumor (low-grade papillary adenocarcinoma) of the temporal bone. Acta Otolaryngol 123:1022–1026CrossRef
11.
Zurück zum Zitat Kupferman ME, Bigelow DC, Carpentieri DF, Bilaniuk LT, Kazahaya K (2004) Endolymphatic sac tumor in a 4-year-old boy. Otol Neurotol 25:782–786CrossRef Kupferman ME, Bigelow DC, Carpentieri DF, Bilaniuk LT, Kazahaya K (2004) Endolymphatic sac tumor in a 4-year-old boy. Otol Neurotol 25:782–786CrossRef
12.
Zurück zum Zitat Hansen MR, Luxford WM (2004) Surgical outcomes in patients with endolymphatic sac tumors. Laryngoscope 114:1470–1474CrossRef Hansen MR, Luxford WM (2004) Surgical outcomes in patients with endolymphatic sac tumors. Laryngoscope 114:1470–1474CrossRef
13.
Zurück zum Zitat Hou ZH, Huang DL, Han DY, Dai P, Young WY, Yang SM (2012) Surgical treatment of endolymphatic sac tumor. Acta Otolaryngol 132:329–336CrossRef Hou ZH, Huang DL, Han DY, Dai P, Young WY, Yang SM (2012) Surgical treatment of endolymphatic sac tumor. Acta Otolaryngol 132:329–336CrossRef
14.
Zurück zum Zitat Wick CC, Manzoor NF, Semaan MT, Megerian CA (2015) Endolymphatic sac tumors. Otolaryngol Clin N Am 48:317–330CrossRef Wick CC, Manzoor NF, Semaan MT, Megerian CA (2015) Endolymphatic sac tumors. Otolaryngol Clin N Am 48:317–330CrossRef
15.
Zurück zum Zitat Gaeta M, Blandino A, Minutoli F, Pandolfo I (1999) Sudden unilateral deafness with endolymphatic sac adenocarcinoma: MRI. Neuroradiology 41:799–801CrossRef Gaeta M, Blandino A, Minutoli F, Pandolfo I (1999) Sudden unilateral deafness with endolymphatic sac adenocarcinoma: MRI. Neuroradiology 41:799–801CrossRef
16.
Zurück zum Zitat Jagannathan J, Butman JA, Lonser RR et al (2007) Endolymphatic sac tumor demonstrated by intralabyrinthine hemorrhage. Case report. J Neurosurg 107:421–425CrossRef Jagannathan J, Butman JA, Lonser RR et al (2007) Endolymphatic sac tumor demonstrated by intralabyrinthine hemorrhage. Case report. J Neurosurg 107:421–425CrossRef
17.
Zurück zum Zitat Butman JA, Kim HJ, Baggenstos M et al (2007) Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease. JAMA 298(1):41–48CrossRef Butman JA, Kim HJ, Baggenstos M et al (2007) Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease. JAMA 298(1):41–48CrossRef
18.
Zurück zum Zitat Li J, Wang M, Sun L et al (2019) The correlation analysis of intralabyrinthine haemorrhage magnetic resonance imaging with hearing loss and prognosis: a retrospective analysis of 207 cases. Clin Otolaryngol 44(6):1096–1100CrossRef Li J, Wang M, Sun L et al (2019) The correlation analysis of intralabyrinthine haemorrhage magnetic resonance imaging with hearing loss and prognosis: a retrospective analysis of 207 cases. Clin Otolaryngol 44(6):1096–1100CrossRef
19.
Zurück zum Zitat Mukherji SK, Albernaz VS, Lo WW et al (1997) Papillary endolymphatic sac tumors: CT, MR imaging, and angiographic findings in 20 patients. Radiology 202:801–808CrossRef Mukherji SK, Albernaz VS, Lo WW et al (1997) Papillary endolymphatic sac tumors: CT, MR imaging, and angiographic findings in 20 patients. Radiology 202:801–808CrossRef
20.
Zurück zum Zitat Poletti AM, Dubey SP, Barbo R et al (2013) Sporadic endolymphatic sac tumor: its clinical, radiological, and histological features, management, and follow-up. Head Neck 35:1043–1047CrossRef Poletti AM, Dubey SP, Barbo R et al (2013) Sporadic endolymphatic sac tumor: its clinical, radiological, and histological features, management, and follow-up. Head Neck 35:1043–1047CrossRef
21.
Zurück zum Zitat Nevoux J, Nowak C, Vellin JF et al (2014) Management of endolymphatic sac tumors: sporadic cases and von Hippel-Lindau disease. Otol Neurotol 35:899–904CrossRef Nevoux J, Nowak C, Vellin JF et al (2014) Management of endolymphatic sac tumors: sporadic cases and von Hippel-Lindau disease. Otol Neurotol 35:899–904CrossRef
Metadaten
Titel
Grading system and surgical approaches for endolymphatic sac tumors
verfasst von
Feitian Li
Yibo Zhang
Wei Li
Qianru Wu
Dedi Kong
Xunbei Shi
Chunfu Dai
Publikationsdatum
06.07.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 5/2021
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-020-06185-3

Weitere Artikel der Ausgabe 5/2021

European Archives of Oto-Rhino-Laryngology 5/2021 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.